CN EN

news

Shanghai, June 23, 2017 – The ‘SAPA-GP 15th Annual Conference’, one of the most premier pharma conference organized by SAPA-GP (Sino-American Pharmaceutical Professionals Association), was held in Philadelphia, PA, USA from June 23 to 24. The conference attracted attendees from highly diverse  backgrounds, including big pharma (Merck, GSK, J & J, Sanofi, Pfizer, AstraZeneca, Roche, Novartis, Amgen, Teva, etc.), biotech/CRO (WuXi AppTec, Alliance Pharma, Frontage Lab, etc.), as well as academic institutions (University of Pennsylvania, Columbia, Drexel, Temple, etc.).

Sundia VP, Dr. Russell Dahl was invited to be the panelist of the panel discussion on ‘US-China CRO landscape: Building Success with Strategic Alliances’ with the distinguished panelist including Dr. Henry Lu from Wuxi Apptec, Dr. Michelle Mack from Crown Bioscience and other executives.

Russell Dahl highlighted that Sundia, as a leading pre-clinical contract research organization (“CRO”), can also play a pivotal role in promoting R&D innovation and partnerships.  Sundia has been recognized for its role as an important, long-term and innovative partner to global pharmaceutical and biotechnology companies throughout the drug discovery and development process. Through breakthrough discoveries and integrated solutions, Sundia has helped its partners accelerate innovation


Register Now!
Webinar: New Modality - Peptides Innovations and a Comprehensive Synthetic Peptide Drug Discovery Platform
June 19, 2024 at 10am ET / 07am PT / 04pm CET
View more
0.187802s
We use necessary cookies to ensure our website functions properly and to keep it secure. These necessary cookies must be enabled. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. You can personalize or withdraw your consent at any moment by clicking on the link "Cookies Settings". For more information on how we use cookies, including the total lifespan of cookies and the identity of third parties intervening on our website, please consult the Privacy Notice available in the site footer.
Accept all